Some research facts about SARMs, Nootropics and other substances you can buy from Enhancetech:

PRL-8-53 improved novel word recall after a week in bottom 60% learners by 200%.
There is only one white paper about PRL-8-53, yet it was considered the most reliable memory enhancing agent by nootropics community quiz.
Contrary to common myths, there is no proof that cardarine reduces weight or waist circumference; actually, the opposite may be likelier.
Cardarine increased running endurance in Kunming mice. World Anti-Doping Agency banned it.
Cardarine prevented endoplasmatic reticulum stress and insulin resistance in mice fed high-fat diet.
Cardarine, 10 mg, reduced plasma triglycerides, LDL-cholesterol, insulin and urinary 8-isoprostanes in man.
At low, 2.5 mg dose, Cardarine had a highly specific effect – it increased “good” HDL cholesterol.
There were 275 studies pertinent for GW501516 (cardarine) in PubMed.
Cardarine had a unfavourable interaction with posttraumatic cartilage.
Ostarine was unlikely to cross blood-brain barrier according to in silico predictions.
Ostarine (3 mg) and ibutamoren (25 mg) increased lean body mass in older adults without overt short-term toxicity.
Ostarine (3 mg) had low incidence of adverse effects in the elderly.
According to many online discussions, elevated doses of ostarine have suppressed endogenous testosterone levels.
Majority of the research related to relatively unresearched Ligandrol is related to detection of metabolites for doping control.
Ligandrol is quite potent but unselective SARM – it increases lean body mass but suppresses endogenous sex hormone levels even at 1 mg dose.
Ibutamoren has been considered quite safe in many studies but unsafe for elderly – it increased risk of congestive heart failure.
Ibutamoren increased blood glucose, insulin and cortisol – these may be unfavourable changes. Blood sugar elevation is greatest concern.
Both SARMs and ibutamoren probably increase bone mineral density.
Ibutamoren lowered total blood testosterone but not free testosterone.
Unlike exogenous growth hormone, ibutamoren increases secretion of growth hormone by its natural, pulsatile pattern.
Lab rat nootropic unifiram is not tested in humans, yet.
Unifiram’s pro-cognitive mechanism of action enhances AMPA signalling and acetylcholine release but exact mechanism is unclear.
Contrary to the common myths, Cardarine, Ibutamoren and YK-11 are not SARMs (selective androgen receptor modulators).
YK11 is a minimally researched SARM-like steroid that is selective for muscle growth.
Boron (3 mg) has memory-enhancing, anti-inflammatory and sex hormone enhancing properties. Yet, it is merely a underrated micronutrient.
The toxicity of boron has been overestimated and its beneficial effects underestimated.
Boron supplementation increases free testosterone, reduces estradiol and decreases sex hormone binding globulin.

Some research facts about SARMs, Nootropics and other substances you can buy from Enhancetech:

PRL-8-53 improved novel word recall after a week in bottom 60% learners by 200%.

There is only one white paper about PRL-8-53, yet it was considered the most reliable memory enhancing agent by nootropics community quiz.

Contrary to common myths, there is no proof that cardarine reduces weight or waist circumference; actually, the opposite may be likelier.

Cardarine increased running endurance in Kunming mice. World Anti-Doping Agency banned it.

Cardarine prevented endoplasmatic reticulum stress and insulin resistance in mice fed high-fat diet.

Cardarine, 10 mg, reduced plasma triglycerides, LDL-cholesterol, insulin and urinary 8-isoprostanes in man.

At low, 2.5 mg dose, Cardarine had a highly specific effect – it increased “good” HDL cholesterol.

There were 275 studies pertinent for GW501516 (cardarine) in PubMed.

Cardarine had a unfavourable interaction with posttraumatic cartilage.

Ostarine was unlikely to cross blood-brain barrier according to in silico predictions.

Ostarine (3 mg) and ibutamoren (25 mg) increased lean body mass in older adults without overt short-term toxicity.

Ostarine (3 mg) had low incidence of adverse effects in the elderly.

According to many online discussions, elevated doses of ostarine have suppressed endogenous testosterone levels.

Majority of the research related to relatively unresearched Ligandrol is related to detection of metabolites for doping control.

Ligandrol is quite potent but unselective SARM – it increases lean body mass but suppresses endogenous sex hormone levels even at 1 mg dose.

Ibutamoren has been considered quite safe in many studies but unsafe for elderly – it increased risk of congestive heart failure.

Ibutamoren increased blood glucose, insulin and cortisol – these may be unfavourable changes. Blood sugar elevation is greatest concern.

Both SARMs and ibutamoren probably increase bone mineral density.

Ibutamoren lowered total blood testosterone but not free testosterone.

Unlike exogenous growth hormone, ibutamoren increases secretion of growth hormone by its natural, pulsatile pattern.

Lab rat nootropic unifiram is not tested in humans, yet.

Unifiram’s pro-cognitive mechanism of action enhances AMPA signalling and acetylcholine release but exact mechanism is unclear.

Contrary to the common myths, Cardarine, Ibutamoren and YK-11 are not SARMs (selective androgen receptor modulators).

YK11 is a minimally researched SARM-like steroid that is selective for muscle growth.

Boron (3 mg) has memory-enhancing, anti-inflammatory and sex hormone enhancing properties. Yet, it is merely a underrated micronutrient.

The toxicity of boron has been overestimated and its beneficial effects underestimated.

Boron supplementation increases free testosterone, reduces estradiol and decreases sex hormone binding globulin.